MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-AP-09-0001626
Lorven Biologics Private Limited - life sciences in Srikakulam, Andhra Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹11.28 Cr
▲ 3% YoY
Net profit · FY 2023
₹26.62 Lakh
Net margin 2.4%
EBITDA · FY 2023
₹1.92 Cr
EBITDA margin 17.1%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹9.2 Cr
Issued & subscribed
Open charges
₹9.79 Cr
Secured borrowings
Company age
11 yrs
Est. 2015
Directors on board
3
As per MCA filings
About Lorven Biologics Private Limited
Data last updated:
Lorven Biologics Private Limited is a private limited company based in Srikakulam, Andhra Pradesh, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 09 October 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U74120AP2015PTC097532. Its GSTIN is 36AACCL9447M1ZW (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.2 Cr. It is led by directors including Venkataramana Mudili (Managing Director) and Srikanth Reddy Devireddy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Modugulapeta Village Govindapuram Post Santhakavitri Mandal, Srikakulam, Andhra Pradesh, India – 532123.
As per the financials filed for FY 2023, the company reported a revenue of ₹11.28 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹26.62 Lakh (net margin 2.4%) and EBITDA of ₹1.92 Cr (EBITDA margin 17.1%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 89% over five years.
The company is associated with 1 brand: Lorven Biologics. As per MCA filings, the company has open charges of ₹9.79 Cr on record. Court records list 2 cases involving the company, including 2 filed against it.
Lorven Biologics Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-09-0001626). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lorvenbiologics.com.
Company details
CIN U74120AP2015PTC097532
Registration Number 097532
Incorporation Date 09 October 2015
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-AP-09-0001626
Key People
Venkataramana Mudili Managing Director Srikanth Reddy Devireddy Director Rahul Kumar Peraka Director Recognitions & Rankings of Lorven Biologics
Contact details
Lorven Biologics Private Limited's registered office is in Srikakulam, Andhra Pradesh. Its website is lorvenbiologics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressModugulapeta Village Govindapuram Post Santhakavitri Mandal, Srikakulam, Andhra Pradesh, India – 532123
- IndustryLife Sciences, Biotechnology
To see the full contact details of Lorven Biologics Private Limited, buy the company report.
Comprehensive company report
Lorven Biologics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Lorven Biologics operates one associated brand: Lorven Biologics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Nutritional and pharmaceutical products are developed and manufactured. | lorvenbiologics.com |
Business activity
The main business activity of Lorven Biologics is professional, scientific and technical. In detail, this covers architecture, engineering activities, technical testing and analysis activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M4 | Architecture, engineering activities, technical testing and analysis activities |
To see the full business activity and turnover split of Lorven Biologics Private Limited, buy the company report.
Financials of Lorven Biologics Private Limited
FY 2025 filings availableLorven Biologics Private Limited reported revenue of ₹11.28 Cr (up 3% YoY) for FY 2023.
Revenue · FY 2023
₹11.28 Cr ▲ 3%
Net profit · FY 2023
₹26.62 Lakh margin 2.4%
EBITDA · FY 2023
₹1.92 Cr margin 17.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▼ 14%
5 years · compounded
▲ 89%
EBITDA CAGR growth
1 year
▲ 33%
3 years · compounded
▲ 44%
5 years · compounded
▲ 57%
Revenue has grown at a compounded annual rate (CAGR) of 89% over five years, including 3% growth in the latest year. EBITDA rose 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹11.28 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.92 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹26.62 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.1% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lorven Biologics Private Limited, buy the company report.
Board of directors of Lorven Biologics Private Limited
Lorven Biologics has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srikanth Reddy Devireddy | Director | 03 Jul 2023 | 3 Years 3 Months | Current |
| Venkataramana Mudili Also directs: Lorven Pathlabs Private Limited, Seyn Biologics Private Limited, Biotris Biologics Private Limited and 3 more | Managing Director | 09 Oct 2015 | 11 Years 0 Months | Current |
| Rahul Kumar Peraka Also directs: Lorven Pathlabs Private Limited, SRK Cleanrooms Private Limited | Director | 01 Mar 2021 | 5 Years 7 Months | Current |
Auditor
Lorven Biologics Private Limited is audited by N.MANIKANTA KUMAR GUPTA for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N.MANIKANTA KUMAR GUPTA | FY 2023 | 244322 |
Shareholding
The shareholding of Lorven Biologics Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Lorven Biologics Private Limited, buy the company report.
Charges & borrowings
Open charges
₹9.79 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Jun 2025 | 101148384 | Others | ₹1.29 Cr | Open | |
| 30 Mar 2024 | 100902418 | State Bank of India | ₹5.5 Cr | Open | |
| 21 Oct 2021 | 100490000 | Sidbi | ₹2 Cr | Open | |
| 01 Jul 2021 | 100454187 | Sidbi | ₹1 Cr | Open |
Total charge records: 4 View all charges
Legal cases
Lorven Biologics Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Total cases
2
Filed against the company
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Buldhana, Maharashtra | Civil suit | Filed against the company by Chaitanya Agro Bio Tech Pvt Ltd Through Authorised Signatory Prasanna Ashokrao Deshpande | Disposed |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Neogrowth Credit Pvt. Ltd. | Disposed |
To see the full case history of Lorven Biologics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lorven Biologics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lorven Biologics has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCL9447M1ZW | Telangana | Active | 24 Oct 2019 |
To see the full GST registrations and return filing status of Lorven Biologics Private Limited, buy the company report.
Recent activity
Lorven Biologics Private Limited has 9 board changes on record since 2015: 3 appointments and 6 cessations. The latest: Srikanth Reddy Devireddy was appointed as Director on 03 Jul 2023.
AGM
Lorven Biologics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 1.29 Cr with Charge ID 101148384 was registered on 29 Jun 2025.
Filing
Lorven Biologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada.
Charges
A charge with State Bank Of India amounted to Rs. 5.50 Cr with Charge ID 100902418 was registered on 30 Mar 2024.
Appointed
Srikanth Reddy Devireddy was appointed as Director.
Charges
A charge with Sidbi amounted to Rs. 2.00 Cr with Charge ID 100490000 was registered on 21 Oct 2021.
Ceased
Venkataramana Mudili ceased to be Director.
Charges
A charge with Sidbi amounted to Rs. 1.00 Cr with Charge ID 100454187 was registered on 01 Jul 2021.
Ceased
Devi Kalyan Kumar Thakasi ceased to be Director.
Appointed
Rahul Kumar Peraka was appointed as Director.
Ceased
Sankara Rao Avula ceased to be Director.
Ceased
Aswanikumar Veer Venkata Yelakurti ceased to be Director.
4 earlier events are in the company report.
Frequently asked questions
Lorven Biologics is an active private limited company based in Srikakulam, Andhra Pradesh, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 09 October 2015 (11+ years old) and is registered under CIN U74120AP2015PTC097532.
Lorven Biologics has 3 current directors:
- Venkataramana Mudili - Managing Director
- Srikanth Reddy Devireddy - Director
- Rahul Kumar Peraka - Director
The latest financial statements of Lorven Biologics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Lorven Biologics is 36AACCL9447M1ZW, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Lorven Biologics is U74120AP2015PTC097532. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lorven Biologics has 2 court cases on record: 2 filed against it.
Lorven Biologics was incorporated on 09 October 2015, making it 11+ years old. It is registered with the Registrar of Companies, Vijayawada.
Srikanth Reddy Devireddy was appointed as Director on 03 Jul 2023. Venkataramana Mudili ceased to be Director on 07 Sep 2021. Devi Kalyan Kumar Thakasi ceased to be Director on 01 Mar 2021. Lorven Biologics has 9 board changes on record in total.
Yes, Lorven Biologics is registered as a small enterprise under Udyam registration (number: UDYAM-AP-09-0001626).
Lorven Biologics can be reached through the website lorvenbiologics.com. Its registered office is in Srikakulam, Andhra Pradesh, India.